There does seem to be a statistical advantage, but the practical advantage is still an open question.

Some people think the benefit of screening is huge, and others say that the reduction in death rates is due primarily to adjuvant therapy. No one has known for sure, and although we still don't know for sure, this is the best set of analyses that is possible given the available information.

I'd do it again if I had to. We made it here all safely. That's the main thing. (Claudia and Joe) have been a blessing. I just wished they had lived a little bit closer.

All seven groups concluded that the decline in the rate of death from breast cancer is a combination of screening and therapy, and not restricted to one or the other.

We don't know the answers for sure. There's still some uncertainty because we don't have perfect data.

The average woman can gain some comfort knowing that both these things that are going on are important.